Impact of aberrant myeloid antigen expression on outcomes of patients with t-cell acute lymphoblastic leukemia
Oman Medical Journal. 2017; 32 (3): 189-193
em Inglês
| IMEMR
| ID: emr-187846
ABSTRACT
Objectives:
To evaluate the impact of myeloid antigen expression on complete remission [CR], event-free survival [EFS], and overall survival [OS] in patients with T-cell acute lymphoblastic leukemia [T-ALL] treated with intensive chemotherapy
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Oman Med. J.
Ano de publicação:
2017
Similares
MEDLINE
...
LILACS
LIS